Published in Ann Intern Med on June 01, 1985
Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A (1988) 1.23
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A (1997) 1.21
Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood (2005) 1.20
Markers predicting progression of human immunodeficiency virus-related disease. Clin Microbiol Rev (1994) 1.19
Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest (2004) 1.17
Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus. J Virol (1991) 1.09
Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest (1986) 1.02
Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. Proc Natl Acad Sci U S A (1995) 1.00
HIV-1-associated thrombocytopenia. The role of splenectomy. Ann Surg (1990) 0.98
Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med (2000) 0.88
Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. J Clin Invest (1992) 0.82
Expression of CD4 by human megakaryocytes. Proc Natl Acad Sci U S A (1990) 0.81
Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia. Proc Natl Acad Sci U S A (1992) 0.80
Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol (1994) 0.79
Recurrent and Massive Life Threatening Epistaxis due to Nasal Heroin Usage. Clin Exp Otorhinolaryngol (2011) 0.75
The epidemiology of immune thrombocytopenia. Can J Infect Dis (1992) 0.75
Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU). Yale J Biol Med (1988) 0.75
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med (2000) 6.07
Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med (1985) 4.78
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (1995) 4.51
Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA (2001) 3.07
Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet (1982) 2.58
Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med (1982) 2.57
Should all pregnant women be tested for their platelet PLA (Zw, HPA-1) phenotype? Br J Haematol (1994) 2.06
Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population. Lancet (1990) 2.00
The effect of azidothymidine on HIV-related thrombocytopenia. N Engl J Med (1988) 1.98
Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest (1969) 1.93
Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost (2001) 1.93
Autoimmune thrombocytopenic purpura. Blood (1980) 1.92
Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet (1991) 1.92
Heterogeneity of human platelets. I. Metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest (1969) 1.88
On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med (1984) 1.87
Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis (1998) 1.79
Autoimmune thrombocytopenic purpura. Semin Hematol (1985) 1.74
Immune adherence hemagglutination: alternative to complement-fixation serology. J Clin Microbiol (1978) 1.69
Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest (1981) 1.63
Heavy chain subclass of human anti-platelet antibodies. Clin Immunol Immunopathol (1973) 1.61
Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost (2003) 1.55
Incidence of heterophil antibody responses in children with infectious mononucleosis. J Pediatr (1979) 1.55
Rheumatoid factor as a cause of positive reactions in tests for Epstein-Barr virus-specific IgM antibodies. Clin Exp Immunol (1979) 1.50
Role of platelets in tumor cell metastases. Ann Intern Med (1981) 1.46
Genetic analysis of an Escherichia coli syndrome. J Bacteriol (1971) 1.46
Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection. Int J Cancer (1978) 1.43
Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood (1998) 1.42
Studies on human platelet glycolysis. Effect of glucose, cyanide, insulin, citrate, and agglutination and contraction on platelet glycolysis. J Clin Invest (1967) 1.41
Priapism in sickle cell disease: possible contributory effect of cocaine use. Arch Intern Med (1993) 1.39
Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res (1992) 1.38
Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood (1978) 1.37
Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int J Cancer (1995) 1.36
Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest (1991) 1.36
Heterophil antigen in bovine sera detectable by immune adherence hemagglutination with infectious mononucleosis sera. Infect Immun (1978) 1.35
In vitro detection of platelet antibody in patients with idiopathic thrombocytopenic purpura and systemic lupus erythematosus. Blood (1969) 1.35
Use of the megathrombocyte as an index of megakaryocyte number. N Engl J Med (1971) 1.35
The Epstein-Barr virus. Sci Am (1979) 1.34
An Escherichia coli mutant with increased messenger ribonuclease activity. Proc Natl Acad Sci U S A (1971) 1.31
Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. J Gen Virol (1998) 1.28
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell (2001) 1.26
Biochemical energetics of simulated platelet plug formation. Effect of thrombin, adenosine diphosphate, and epinephrine on intra- and extracellular adenine nucleotide kinetics. J Clin Invest (1968) 1.26
Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. J Clin Microbiol (1987) 1.25
Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci U S A (1988) 1.23
Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost (1995) 1.22
Thrombocytopenia in homosexual patients. Prognosis, response to therapy, and prevalence of antibody to the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.22
GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci U S A (1997) 1.21
Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis (1979) 1.19
A solid-phase radioimmunoassay for bound anti-platelet antibody: studies on 45 patients with autoimmune platelet disorders. J Lab Clin Med (1979) 1.16
In vitro activation, infectivity, and production of endogenous type-C virus from OM rats. J Natl Cancer Inst (1975) 1.15
Antiplatelet treatment of thrombotic thrombocytopenic purpura. Ann Intern Med (1977) 1.14
Biochemical and biophysical aspects of human platelet adhesion to collagen fibers. J Clin Invest (1971) 1.14
Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. Cancer Res (1984) 1.14
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation (1995) 1.13
Risk factors for Lyme disease in a small rural community in northern California. Am J Epidemiol (1992) 1.12
Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual. Virology (1990) 1.08
Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol (1997) 1.08
Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer (1978) 1.07
Role of platelets in tumor cell metastases. Ann N Y Acad Sci (1981) 1.05
Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood (2000) 1.04
Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis (1998) 1.04
Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem (2000) 1.03
Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci U S A (1980) 1.03
Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease. J Clin Microbiol (1990) 1.03
Crossed immunoelectrophoresis of human platelet membranes. The major antigen consists of a complex of glycoproteins, GPIIb and GPIIIa, held together by Ca2+ and missing in Glanzmann's thrombasthenia. J Biol Chem (1982) 1.03
Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med (1972) 1.03
Anti-F(ab')2 antibodies in thrombocytopenic patients at risk for acquired immunodeficiency syndrome. J Clin Invest (1986) 1.02
Detection of multiple Epstein-Barr viral strains in allogeneic bone marrow transplant recipients. J Med Virol (1992) 1.01
Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer (1993) 1.01
Recurrent aphthous ulcers in association with HIV infection. Description of ulcer types and analysis of T-lymphocyte subsets. Oral Surg Oral Med Oral Pathol (1991) 1.00
Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. Proc Natl Acad Sci U S A (1995) 1.00
Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves' disease and Hashimoto's thyroiditis. Ann Intern Med (1981) 0.99
Presence of a nonsplenic platelet pool. Blood (1977) 0.99
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer (1998) 0.99
Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture. J Clin Microbiol (1990) 0.97
Malaria, sex, and place of residence as factors in antibody response to Epstein-Barr virus in Ghana, West Africa. Lancet (1981) 0.97
A new mechanism for tumor induced platelet aggregation. Comparison with mechanisms shared by other tumor with possible pharmacologic strategy toward prevention of metastases. Int J Cancer (1983) 0.97
Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood (1998) 0.96
Crossed immunoelectrophoresis of human platelet membranes. Diminished major antigen in Glanzmann's thrombasthenia and Bernard-Soulier syndrome. J Biol Chem (1980) 0.96
Platelet function and coagulation profile in lupus erythematosus. Studies in 50 patients. Ann Intern Med (1974) 0.95
Presence of the seven transmembrane thrombin receptor on human tumour cells: effect of activation on tumour adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol (1996) 0.95
Detection of splenic anti-platelet antibody synthesis in idiopathic autoimmune thrombocytopenic purpura (ATP). Br J Haematol (1972) 0.95
A monoclonal anti-platelet antibody with decreased reactivity for autoimmune thrombocytopenic platelets. Proc Natl Acad Sci U S A (1983) 0.95
Heterogeneity of human platelets. Metabolic and kinetic evidence suggestive of young and old platelets. Ser Haematol (1971) 0.94
Lack of effect of in vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT26 colon carcinoma, Lewis lung carcinoma, or B16 amelanotic melanoma cells. Cancer Res (1984) 0.94
Human megakaryocytes have a CD4 molecule capable of binding human immunodeficiency virus-1. Blood (1993) 0.93
Serology of Legionnaires disease: comparison of indirect fluorescent antibody, immune adherence hemagglutination, and indirect hemagglutination tests. J Clin Microbiol (1979) 0.93
Oral viral leukoplakia--a new AIDS-associated condition. Adv Exp Med Biol (1985) 0.93
Heterogeneity of human fibrinogen: possible relation to proteolysis by thrombin and plasmin as studies by SDS-polyacrylamide gel electrophoresis. Biochem Biophys Res Commun (1970) 0.92
Platelet counts in infants of women with autoimmune thrombocytopenia: effects of steroid administration to the mother. N Engl J Med (1981) 0.92
The megathrombocyte as an index of platelet production. Br J Haematol (1974) 0.91
On the "easy bruising" syndrome with normal platelet count. A study of 75 patients. Ann Intern Med (1975) 0.91
Platelets and microtubules. Effect of colchicine and D2O on platelet aggregation and release induced by calcium ionophore A23187. J Clin Invest (1980) 0.91
Requirement of iron for platelet protein synthesis. Biochem Biophys Res Commun (1973) 0.91
Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. Ann Intern Med (1988) 0.91
Evidence suggesting the regulation of a coagulation factor levels in rabbits by a transferable plasma agent. Blood (1976) 0.91